Cytokinetics Announces Data From Phase 1 Study of CK-4021586
Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in Q4 2024 SOUTH SAN ...
Cytokinetics to Participate in September Investor Conferences
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in the following ...
Dad, 41, kept getting pneumonia. It was sign of congestive heart failure
Son Vang felt like he had the flu and developed pneumonia several times. Doctors realized he had congestive heart failure and ...
Endovascular therapy improves left ventricular diastolic function in heart failure with preserved ejection fraction
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
HealthDay on MSN4d
Endovascular Therapy Improves Left Ventricular Diastolic Function in HFpEF
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
News Medical4d
Advanced Cardiotoxicity Testing Using Multi-Channel iPSC Cardiomyocytes
Multi-channel models enhance cardiotoxicity testing, offering more accurate and human-relevant insights for safer drug ...
Milestone Pharmaceuticals to Host Investor KOL Event
Managing PSVT and Studying AFib-RVR in the Community SettingHosted 10 am ET, Tuesday, October 8, 2024MONTREAL and ...
News Medical on MSN13d
World champion marathon runner’s life study highlights benefits and risks of life-long endurance exercise
Decades of intense marathon training have preserved heart function in a 77-year-old, highlighting benefits and risks of ...
Health on MSN11d
What To Know about Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
It affects about 1 in 2,000 to 1 in 5,000 people, most of whom are between 20 and 40 years old.With ARVC, scar and fatty ...
Boston Scientific Gets FDA Approval For Expanded Indication Of INGEVITY+ Pacing Leads
(RTTNews) - Boston Scientific Corporation (BSX) Tuesday said it received Food and Drug Administration's approval for the expanded indication of INGEVITY+ Pacing Leads to include conduction system ...